The boy, named Daoming, has been battling rhabdomyosarcoma — a type of soft tissue sarcoma affecting his brain and nose — for ...

The following is a summary of "Clinical course and prognostic factors of patients with dedifferentiated liposarcoma: a ...

Bachelorette alum Ali Fedotowsky-Manno shared an update on her dog's brain tumor several months after her husband, Kevin ...

Sarcomas are among the rarest and most enigmatic forms of cancer, accounting for just 1% of all adult cancer diagnoses ...

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

It was May 2018 and Sue Harte and her husband, Damien, were sipping a glass of celebratory champagne in Morocco, giddy with ...

A Chinese traffic police brigade helped fulfil the dream of an eight-year-old boy with rare cancer, allowing him to ...

A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

Telix Pharmaceuticals Limited today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx ...

The family of a Southampton teenager who died after a shocking cancer diagnosis have told of a ‘kind, strong and remarkable’ young girl ...

SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft ...

MELBOURNE - Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX), a pharmaceutical company with a market capitalization of $5.58 billion and strong financial health according to InvestingPro ...